StockData
Immunome Inc. logo

Immunome Inc. (IMNM) stock

IMNMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$17.18−0.43 (-2.44%)

Close on Nov 17, 2026Market cap $1.95BP/E –Yield –

Immunome price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Immunome's price to book ratio was 3.7× on Nov 11, 2026, against 6.4× a year earlier. Over the last 5 years it ranged from 0.9× to 33.3×, with a median of 3.5×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20263.7×−3.8
2025Dec 31, 20257.5×+4.5
2024Dec 31, 20243.0×−18.5
2023Dec 29, 202321.5×+20.3
2022Dec 30, 20221.2×−1.7
2021Dec 31, 20212.9×–

More Immunome figures

See a number that looks wrong?